Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
4.300
-0.220 (-4.87%)
At close: Oct 17, 2025, 4:00 PM EDT
4.330
+0.030 (0.70%)
After-hours: Oct 17, 2025, 7:54 PM EDT
Cassava Sciences Market Cap
Cassava Sciences has a market cap or net worth of $207.72 million as of October 17, 2025. Its market cap has decreased by -83.93% in one year.
Market Cap
207.72M
Enterprise Value
95.34M
1-Year Change
-83.93%
Ranking
Category
Stock Price
$4.30
Market Cap Chart
Since July 14, 2000, Cassava Sciences's market cap has decreased from $212.59M to $207.72M, a decrease of -2.29%. That is a compound annual growth rate of -0.09%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 17, 2025 | 207.72M | 82.95% |
Dec 31, 2024 | 113.54M | -88.04% |
Dec 29, 2023 | 949.34M | -22.98% |
Dec 30, 2022 | 1.23B | -29.52% |
Dec 31, 2021 | 1.75B | 633.58% |
Dec 31, 2020 | 238.38M | 166.23% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 720.73B |
Johnson & Johnson | 465.34B |
AbbVie | 405.55B |
UnitedHealth Group | 322.96B |
AstraZeneca | 260.83B |
Novartis AG | 254.64B |
Novo Nordisk | 237.72B |
Abbott Laboratories | 223.72B |